Drugs / Metoclopramide Sulfone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06167837 | Oct 2023 → May 2025 | — | King Chulalongkorn Memorial Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Metoclopramide Sulfone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06167837 ↗ |
| Route | Intravenous | “intravenous metoclopramide” NCT06167837 ↗ |